Abbott has launched its over-the-counter continuous glucose monitoring system in the U.S., the company said on Thursday, ...
San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing ...
The FDA cleared Dexcom's Stelo in March. Abbott followed in June, collecting FDA clearances for two separate continuous glucose monitoring systems, the Libre Rio and the Lingo. While the Libre Rio ...
The Dexcom Stelo Glucose Biosensor System is an integrated CGM intended for people 18 and older who do not use insulin. Stelo is a small, gray device worn on the upper arm, about the size of a ...
You have permission to edit this article. Edit Close Newsletter Facebook Instagram ...
Abbott Follows Rival Dexcom With OTC Glucose Monitor Launch in US By Sneha S K (Reuters) -Abbott has launched its over-the-counter continuous glucose monitoring system in the U.S., the company ...
“Dexcom has been at the forefront ... INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously ...